A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan
Regular
Direct
3 Year Absolute Returns
90.46% ↑
NAV (₹) on 18 Jun 2026
37.33
1 Day NAV Change
0.46%
Risk Level
Very High Risk
Rating
-
Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by Aditya Birla Sun Life AMC Limited. Launched on 20 Jun 2019, investors can ... Read more
NAV History
Fund Details
Min. SIP Amount
₹100
Inception Date
20 Jun 2019
Min. Lumpsum Amount
₹ 500
Fund Age
7 Yrs
AUM
₹ 950.31 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
0.99%
Scheme Type
Open Ended
Exit Load
1%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 950.31 Cr
Equity
489.44%
Money Market & Cash
10.65%
Other Assets & Liabilities
0.17%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 73.54% |
| Hospitals & Medical Services | 20.10% |
| Treps/Reverse Repo | 3.23% |
| Chemicals - Speciality | 1.52% |
| Insurance Distributor | 1.01% |
| Chemicals - Organic - Benzene Based | 0.65% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 13.17% | ₹ 118.64 | Pharmaceuticals |
| Apollo Hospitals Enterprise Limited | 7.20% | ₹ 64.86 | Hospitals & Medical Services |
| Torrent Pharmaceuticals Limited | 4.76% | ₹ 42.87 | Pharmaceuticals |
| J.B. Chemicals & Pharmaceuticals Limited | 4.71% | ₹ 42.40 | Pharmaceuticals |
| Aurobindo Pharma Limited | 4.49% | ₹ 40.47 | Pharmaceuticals |
| Ajanta Pharmaceuticals Limited | 4.05% | ₹ 36.50 | Pharmaceuticals |
| Lupin Limited | 4.00% | ₹ 36.01 | Pharmaceuticals |
| Mankind Pharma Ltd | 3.88% | ₹ 34.95 | Pharmaceuticals |
| Fortis Healthcare Limited | 3.87% | ₹ 34.85 | Hospitals & Medical Services |
| Abbott India Limited | 3.65% | ₹ 32.90 | Pharmaceuticals |
| Emcure Pharmaceuticals Ltd | 3.32% | ₹ 29.86 | Pharmaceuticals |
| Cipla Limited | 3.30% | ₹ 29.74 | Pharmaceuticals |
| IPCA Laboratories Limited | 2.86% | ₹ 25.80 | Pharmaceuticals |
| Shilpa Medicare Ltd | 2.51% | ₹ 22.65 | Pharmaceuticals |
| CORONA Remedies Ltd | 2.24% | ₹ 20.20 | Pharmaceuticals |
| SAI Life Sciences Ltd | 2.20% | ₹ 19.78 | Pharmaceuticals |
| Alkem Laboratories Limited | 2.10% | ₹ 18.92 | Pharmaceuticals |
| Procter & Gamble Health Limited | 2.04% | ₹ 18.36 | Pharmaceuticals |
| Divi's Laboratories Limited | 1.88% | ₹ 16.91 | Pharmaceuticals |
| Jupiter Life Line Hospitals Ltd | 1.79% | ₹ 16.11 | Hospitals & Medical Services |
| SANOFI CONSUMER HEALTHCARE | 1.67% | ₹ 15.03 | Chemicals - Speciality |
| Thyrocare Technologies Limited | 1.58% | ₹ 14.19 | Hospitals & Medical Services |
| Clearing Corporation of India Limited | 1.50% | ₹ 13.48 | Others |
| Dr. Reddys Laboratories Limited | 1.45% | ₹ 13.09 | Pharmaceuticals |
| METROPOLIS HEALTHCARE LIMITED | 1.42% | ₹ 12.80 | Hospitals & Medical Services |
| ALEMBIC PHARMACEUTICALS LIMITED | 1.35% | ₹ 12.16 | Pharmaceuticals |
| Pfizer Limited | 1.34% | ₹ 12.04 | Pharmaceuticals |
| Jubilant Pharmova Ltd | 1.20% | ₹ 10.83 | Pharmaceuticals |
| ANTHEM BIOSCIENCES LIMITED | 1.20% | ₹ 10.77 | Pharmaceuticals |
| Biocon Limited | 1.08% | ₹ 9.77 | Pharmaceuticals |
| Suraksha Diagnostic Ltd | 1.06% | ₹ 9.50 | Hospitals & Medical Services |
| Piramal Pharma Ltd | 1.04% | ₹ 9.36 | Pharmaceuticals |
| Medi Assist Healthcare Services Ltd | 1.00% | ₹ 9.02 | Insurance Distributor |
| Vijaya Diagnostic Centre Limited | 0.98% | ₹ 8.83 | Hospitals & Medical Services |
| Gland Pharma Limited | 0.97% | ₹ 8.75 | Pharmaceuticals |
| Dr. Lal Path Labs Limited | 0.94% | ₹ 8.51 | Hospitals & Medical Services |
| GlaxoSmithKline Pharmaceuticals Limited | 0.85% | ₹ 7.66 | Pharmaceuticals |
| Max Healthcare Institute Limited | 0.77% | ₹ 6.95 | Hospitals & Medical Services |
| Vinati Organics Limited | 0.69% | ₹ 6.24 | Chemicals - Organic - Benzene Based |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 7.58% | 13.88% | 11.85% | 23.96% |
| Category returns | 1.67% | 5.74% | 7.21% | 22.82% |
Fund Objective
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
AMC Details
Name
Aditya Birla Sun Life AMC Limited
Date of Incorporation
23 Dec 1994
CEO
Mr. A Balasubramanian
CIO
Type
Pvt.Sector-Joint Venture (Indian)
Address
One World Center, Tower 1, 17th Floor,
Jupiter Mills,
Senapati Bapat Marg,
Elphinstone Road, Mumbai, Maharashtra, India - 400013
Website
https://mutualfund.adityabirlacapital.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.90 | 202.92% | 342.40% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.90 | 202.92% | 342.40% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.90 | 202.92% | 342.40% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.37 | 198.79% | 324.40% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.37 | 198.79% | 324.40% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.37 | 198.79% | 324.40% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.24 | 16.07% | 199.31% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.24 | 16.07% | 199.31% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.24 | 16.07% | 199.31% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.22 | 14.91% | 189.42% | 0.00% | ₹9,724 | 1.75% |
Very High
|
Top Funds from Aditya Birla Sun Life AMC Limited
FAQs
What is the current NAV of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth?
The current Net Asset Value (NAV) of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth is ₹37.33 as of 18 Jun 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth?
The Assets Under Management (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth is ₹950.31 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth?
Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth has delivered returns of 13.88% (1 Year), 23.96% (3 Year), 14.52% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth?
Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth?
The minimum lumpsum investment required for Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan Growth is ₹500. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹100, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
These 5 Small-Cap Mutual Funds Delivered Over 27% Returns in 3 Years: Check Full List -
Top Aggressive Hybrid Mutual Funds to Consider in June 2026: A Simple Guide for Steady Growth -
What Happens If You Miss Stock Market's Best Days? FundsIndia Reveals Shocking Impact -
Tata Gold ETF: AMC Limits Direct Subscriptions And Lumpsum Inflows From June 8 -
Your Portfolio Can Pay You Every Single Month -
Good Returns: Everyone Wants The “Latest Launch”. But Does That Always Mean Better Value? -
What Is Short Duration Mutual Fund? How it Works? Top 5 Mutual Funds That Delivered Strong Returns -
Unclaimed financial assets portal launched to help Indians trace deposits, insurance, shares -
Why Staying Invested In SIPs For 10 Years Can Greatly Reduce Your Chances Of Losing Money? -
Best Mutual Funds In 2026: Top 5 Infrastructure Funds That Delivered Up To 29% Returns In 3 Years
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+